0R15 8884.0068 1.4156% 0R1E 9171.0 0.0% 0M69 None None% 0R2V 255.5 0.3929% 0QYR 1619.0 0.0% 0QYP 434.5 -0.344% 0RUK None None% 0RYA 1600.0 4.5752% 0RIH 195.2 1.3763% 0RIH 195.2 1.3763% 0R1O 225.5 9877.8761% 0R1O None None% 0QFP None None% 0M2Z 255.0 0.2457% 0VSO 33.3 -6.4738% 0R1I None None% 0QZI 596.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 236.3943 1.5483%

Feedback PLC

Healthcare GB FDBK

16.75GBP
-(-%)

Last update at 2024-12-23T12:39:00Z

Day Range

16.8617.00
LowHigh

52 Week Range

68.00184.90
LowHigh

Fundamentals

  • Previous Close 16.75
  • Market Cap9.67M
  • Volume908505
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.39402M
  • Revenue TTM1.02M
  • Revenue Per Share TTM0.08
  • Gross Profit TTM 0.94M
  • Diluted EPS TTM-0.22

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Income before tax -3.37409M -2.51122M -2.05985M -1.41446M -1.13057M
Minority interest - - - - -
Net income -2.91818M -2.11859M -1.61951M -1.08746M -0.97311M
Selling general administrative - - 2.27M 1.83M 1.58M
Selling and marketing expenses - - - - -
Gross profit 0.94M 0.49M 0.26M 0.45M 0.56M
Reconciled depreciation 0.81M 0.55M 0.05M 0.03M 0.11M
Ebit -3.42195M -2.51323M -2.06013M -1.41506M -1.13186M
Ebitda -2.61262M -1.96030M -2.01137M -1.38479M -1.02507M
Depreciation and amortization 0.81M 0.55M 0.05M 0.03M 0.11M
Non operating income net other - - - - -
Operating income -3.42195M -2.51323M -2.06013M -1.41506M -1.13186M
Other operating expenses 4.45M 3.10M 2.35M 1.87M 1.69M
Interest expense 0.00201M 0.00201M 0.00028M 0.00128M 0.00128M
Tax provision -0.45591M -0.39263M -0.44033M -0.32700M -0.15746M
Interest income 0.05M 0.00201M 0.00028M 0.00061M 0.00128M
Net interest income 0.05M 0.00201M 0.00028M 0.00061M 0.00128M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.45591M -0.39263M -0.44033M -0.32700M -0.15746M
Total revenue 1.02M 0.59M 0.29M 0.45M 0.56M
Total operating expenses 4.36M 3.00M 2.32M 1.86M 1.69M
Cost of revenue 0.08M 0.10M 0.03M 0.00187M 0.00490M
Total other income expense net 0.05M 0.00201M 0.00028M 0.00061M 0.00128M
Discontinued operations - - - - -
Net income from continuing ops -2.91818M -2.11859M -1.61951M -1.08746M -0.97311M
Net income applicable to common shares -2.91818M -2.11859M -1.61951M -1.08746M -0.97311M
Preferred stock and other adjustments - - - - -
Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Total assets 11.72M 14.30M 5.82M 2.50M 1.49M
Intangible assets 3.71M 3.29M 2.68M 1.30M 0.45M
Earning assets - - - - -
Other current assets 0.70M 0.70M 0.91M 0.46M 0.49M
Total liab 0.86M 0.59M 0.55M 0.73M 0.54M
Total stockholder equity 10.87M 13.71M 5.27M 1.77M 0.95M
Deferred long term liab - - - - -
Other current liab 0.79M 0.43M 0.35M 0.60M 0.47M
Common stock 6.67M 6.67M 2.67M 1.35M 0.93M
Capital stock 6.67M 6.67M 2.67M 1.35M 0.93M
Retained earnings -11.76725M -8.84907M -6.73048M -5.11097M -4.11565M
Other liab - - 0.00399M 0.00988M 0.05M
Good will 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Other assets 0.00000M 0.00000M - - -
Cash 7.32M 10.31M 2.22M 0.73M 0.54M
Cash and equivalents - - - - -
Total current liabilities 0.86M 0.59M 0.55M 0.72M 0.50M
Current deferred revenue - - - - -
Net debt -7.31753M -10.30558M -2.22086M -0.73265M -0.54073M
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity 5.10M 2.18M 4.06M 3.76M 4.13M
Property plant equipment 0.01M 0.00837M 0.01M 0.01M 0.00643M
Total current assets 8.00M 11.01M 3.13M 1.19M 1.03M
Long term investments - - - - -
Net tangible assets 7.16M 10.42M 2.59M 0.47M 0.50M
Short term investments - - - - -
Net receivables 0.13M 0.63M 0.86M 0.43M 0.46M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.06M 0.17M 0.20M 0.12M 0.03M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -0.01859M -0.01706M
Additional paid in capital - - - - -
Common stock total equity - - - 1.35M 0.93M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -3.72586M 0.00000M 0.00000M -1.30861M 0.46M
Deferred long term asset charges - - - - -
Non current assets total 3.73M 3.30M 2.70M 1.31M 0.46M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Investments -1.19683M -1.15268M -1.43527M -0.88253M -0.40045M
Change to liabilities -0.10357M -0.03010M 0.08M 0.09M 0.00887M
Total cashflows from investing activities -1.19683M -1.15268M -1.43527M -0.88253M -0.40045M
Net borrowings - - - - -
Total cash from financing activities -0.00083M 10.49M 4.96M 1.86M 1.29M
Change to operating activities 0.35M 0.10M -0.33454M 0.11M -0.15192M
Net income -3.37409M -2.51122M -2.05985M -1.41446M -1.13057M
Change in cash -2.98804M 8.08M 1.49M 0.19M -0.09155M
Begin period cash flow 10.31M 2.22M 0.73M 0.54M 0.63M
End period cash flow 7.32M 10.31M 2.22M 0.73M 0.54M
Total cash from operating activities -1.79038M -1.25359M -2.03277M -0.78665M -0.98319M
Issuance of capital stock - 10.49M 4.96M 1.86M 1.29M
Depreciation 0.81M 0.55M 0.05M 0.03M 0.11M
Other cashflows from investing activities 0.05M 0.00201M 0.00028M 0.00061M 0.00128M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.09M -0.19875M 0.07M 0.10M -0.11432M
Sale purchase of stock -0.00083M - 4.96M 1.86M 1.29M
Other cashflows from financing activities -10.49099M -1.15268M -1.43527M -0.88253M -0.40045M
Change to netincome -0.02585M 0.44M -0.27800M -0.02859M 0.18M
Capital expenditures 1.24M 1.15M 1.44M 0.88M 0.40M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.34M -0.12895M -0.18401M 0.30M -0.25737M
Stock based compensation 0.08M 0.07M 0.16M 0.05M 0.26M
Other non cash items -0.04787M -0.00201M -0.00028M -0.00061M 0.04M
Free cash flow -3.03508M -2.40829M -3.46832M -1.66979M -1.38492M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
FDBK
Feedback PLC
- -% 16.75 - - 9.56 0.89 2.29 -0.8995
CRW
Craneware Plc
-5.0 0.23% 2215.00 85.71 26.53 3.65 2.44 3.65 12.32
INHC
Induction Healthcare Group PLC
- -% 9.00 - 21.51 1.76 0.96 1.48 -1.6421
RENX
Renalytix AI plc
- -% 10.75 - - 6.44 8.06 3.81 -0.2835
COG
Cambridge Cognition Holdings Plc
- -% 34.00 - 238.10 1.42 18.04 0.76 -2.6598

Reports Covered

Stock Research & News

Profile

Feedback plc, a medical imaging technology company, engages in the provision of software and systems to those working in the field of medical imaging. Its products include Bleepa, a secure clinical communications and data viewing platform that facilitates the sharing of clinical-grade medical images; CareLocker, a patient centric cloud architecture that provides secure data portability; and Bleepa Box, a technology for sharing DICOM images and other clinical data over mobile networks with the company's dedicated cloud environment, CareLocker, for subsequent display and review within Bleepa. The company also offers Cadran, a picture archiving storage, management, and display system for medical images; TexRAD, a patent-protected algorithm that extracts and quantifies texture features in pre-existing medical images; and TexRAD Lung, a software tool for the analysis of lung cancer for clinical use. Feedback plc was incorporated in 1958 and is headquartered in London, the United Kingdom.

Feedback PLC

201 Temple Chambers, London, United Kingdom, EC4Y 0DT

Key Executives

Name Title Year Born
Dr. Thomas James Oakley B.Sc. CEO & Director 1989
Mr. Aneshkumar Ishwarbhai Patel CFO, Company Sec. & Director 1982
Mr. Michael Peter Hayball Technical Director 1967
Nicolas Mayhew Chief Marketing Lead NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions